This role is for a seasoned rare disease commercialization leader who thrives at the intersection of science, strategy, and execution. The individual will have led or been a critical architect of at least one rare disease launch and understands the nuances of a small-patient, high-science category. The Senior Director, Head of Marketing will serve as the commercial brand authority for Calci (encaleret), BridgeBio's oral CaSR negative allosteric modulator in NDA review for Autosomal Dominant Hypocalcemia Type 1 (ADH1). This is a first-in-class asset targeting a chronically underserved rare endocrine population, and this role represents a defining commercial leadership opportunity. The position requires owning the full marketing function for Calci, including HCP marketing, patient marketing, and KOL engagement under a single integrated brand strategy. The role reports directly to the SVP, Sales & Marketing — Endocrinology and requires weekly on-site presence in both San Francisco and Palo Alto offices. This is a role for someone who can write the playbook, not follow one.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior